Surgical resection of vulvar metastases of endometrial cancer: A presentation of two cases

Journal of Lower Genital Tract Disease

Volumn 11, Issue 2, 2007, Pages 118-121

  Temkin, Sarah M ^a,b   Hellman, Mira ^a   Lee, Yi Chun ^a   Abulafia, Ovadia ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Endometrial carcinoma; Recurrence; Surgical resection; Vulva

Indexed keywords

DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; ENDOMETRIUM CANCER; FEMALE; HUMAN; INGUINAL REGION; METASTASIS; SURVIVAL TIME; VULVA CANCER;

ADENOCARCINOMA; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 34247162694     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.lgt.0000236970.35125.4b     Document Type: Article

References (19)

1. Jemal A, Seigel R, Ward E, Murray T, Xu J, Smigal D, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Endometrial carcinoma-relative effectiveness of adjuvant radiation vs therapy reserved for relapse. Gynecol Oncol 1996;60:177-83.
3. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51.
4. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, et al. Surgical pathologic risk factors in clinical stage I and II endometrial carcinoma. Gynecol Oncol 1991;40:55-65.
5. Aalders JG, vd Syde R, Poppema S, Szabo BG, Janssens J. Postoperative external irradiation and prognostic parameters in stage I endometrial cancer. Obstet Gynecol 1980;56:419-26.
6. Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME. Principles and Practice of Gynecologic Oncology, 4th Ed. Philadelphia, PA: Lippincott & Williams, 2004.
7. Santin AD, Bellone S, O'Brien TJ, Pecorrelli S, Cannon MJ, Roman JJ. Current treatment options for endometrial cancer. Expert Rev Anticancer Ther 2004;4:679-89.
8. Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgastrim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2004;22:2159-66.
9. Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT. High dose megestrol acetate in advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1996;14:357-61.
10. Thigpen JT, Brady MF, Homesley HD, Soper JT, Bell J. Tamoxifen in the treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2001;19:364-7.
11. Fiorica JV, Brunetto VL, Hanjani P, Lentz SS, Mannel R, Andersen W. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:10-4.
12. Whitney CW, Brunetto VL, Zaino RJ, Lentz SS, Sorosky J, Armstrong DK, et al. Phase II trial of alternating courses of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:4-9.
13. Kuten A, Grisbey PW, Perez CA, Fineberg B, Garcia DM. Results of radiotherapy in recurrent endometrial carcinoma. A retrospective analysis. Int J Radiat Oncol Biol Phys 1989;17:29.
14. Greven K, Olds W. Isolated vaginal recurrences of endometrial adenocarcinoma and their management. Cancer 1986;60:419.
15. Mandell L, Nori D, Hilaris B. Recurrent Stage I endometrial carcinoma: results of treatment and prognostic factors. Int J Radiat Oncol Biol Phys 1985;11:1103.
16. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 2003;89:201-9.
17. Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP. Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol 1999;75:99-102.
18. Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ. Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer 2004;14:399-422.
19. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg 1993;79:210-6.